Article in Clinical journal of the American Society of Nephrology : CJASN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
22 authors.
Sarah J SchraubenDepartment of Medicine and Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0003-2557-5161
Xiaoming ZhangDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0001-8669-4530
Dawei XieDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Steven CocaSection of Nephrology, Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Jason H GreenbergSection of Nephrology, Department of Pediatrics, Clinical and Translational Research Accelerator, Yale University School of Medicine, New Haven, Connecticut.ORCID 0000-0001-5874-1109
Joachim H IxDivision of Nephrology-Hypertension, Department of Medicine, University of California San Diego, San Diego, California.ORCID 0000-0002-8084-9869
Michael G ShlipakKidney Health Research Collaborative, San Francisco VA Healthcare System, University of California San Francisco, San Francisco, California.ORCID 0000-0002-9559-204
Chi-Yuan HsuDivision of Nephrology, San Francisco School of Medicine, University of California San Francisco, San Francisco, California.ORCID 0000-0001-8182-1238
Jonathan J TaliercioDepartment of Kidney Medicine, Medical Subspecialties Institute, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0003-4320-7151
Chirag R ParikhDivision of Nephrology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.ORCID 0000-0001-9051-7385
Orlando GutierrezSection of Nephrology, Department of Medicine, University of Alabama, Birmingham, Alabama.ORCID 0000-0001-6593-3571
Mark J SarnakDivision of Nephrology, Tufts Medical Center, Boston, Massachusetts.ORCID 0000-0003-1860-6302
Mirela A DobreDivision of Nephrology and Hypertension, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio.ORCID 0000-0002-9059-9998
Debbie CohenDepartment of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0002-1325-315
Jeffrey R SchellingDepartments of Physiology and Biophysics and Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio.ORCID 0000-0003-3503-2208
Panduranga S RaoDivision of Nephrology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-4699-5395
Mark L UnruhDepartment of Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico.ORCID 0000-0001-7103-656
Ana C RicardoDivision of Nephrology, University of Illinois at Chicago, Chicago, Illinois.ORCID 0000-0001-8670-3644
Sushrut WaikarBoston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.
Paul L KimmelDepartment of Medicine, George Washington University, Washington, DC.
Joseph V BonventreDivision of Renal Medicine and Engineering in Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0001-7144-386
CKD Biomarkers Consortium and the CRIC investigators
Funding
Continuation of the Coordinating Center for the Chronic Renal Insufficiency Cohort (CRIC) StudyU24DK060990 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Amanda Hyre Anderson, Laura M Dember · 2018 to 2026
$21.5M
KIDNEY INJURY MOLECULE-1 IN EPITHELIAL REPAIRR01DK072381 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 2005 to 2025
$8.6M
Mechanisms of Ischemic Kidney Injury and RepairR01DK039773 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI JOSEPH VINCENT BONVENTRE · 1987 to 2026
$6.2M
Acute kidney injury among patients with chronic kidney diseaseR01DK114014 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HSU, CHI-YUAN · 2018 to 2021
$3.0M
Sleep-Disordered Breathing and Outcomes in Chronic Kidney DiseaseR01DK118736 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RICARDO, ANA CATHERINE · 2019 to 2023
$2.9M
Kidney-Associated Diseases after Congenital Heart disease surgery In ChildrenR01DK135518 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI Jason Henry Greenberg, Derek K Ng · 2024 to 2026
$2.1M
Myocardial Fibrosis in Hypertensive Adults with and without Chronic Kidney DiseaseR01HL141846 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI DOBRE, MIRELA AURORA · 2018 to 2022
$2.0M
Beyond the Glomerulus: Novel Clinical Markers of Kidney Health and PrognosisU01DK102730 · NIDDK · TUFTS MEDICAL CENTER · PI GUTIERREZ, ORLANDO M, IX, JOACHIM H · 2016 to 2020
$1.9M
Identification of CKD and CVD BiomarkersU01DK106965 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI BRUNENGRABER, HENRI, HOSTETTER, THOMAS HEARD · 2015 to 2019
$1.6M
Acute Kidney Injury in Children with Chronic Kidney DiseaseR01DK135650 · NIDDK · YALE UNIVERSITY · PI Jason Henry Greenberg · 2023 to 2026
$1.4M
Physical Function in Chronic Kidney Disease: Characterizing the Natural History and Relationship to Clinical OutcomesR01DK137087 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Sarah Jeanne Schrauben · 2023 to 2026
$1.3M
A Mixed Methods Study of Chronic Kidney Disease (CKD) Self-ManagementK23DK118198 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI SCHRAUBEN, SARAH JEANNE · 2019 to 2023
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Urine Biomarkers for Diabetic Kidney Disease Progression in Participants of the Chronic Renal Insufficiency Cohort Study. · full record | OpenQuestion